Abstract

BackgroundPre-eclampsia (PE) remains a disease of theories despite extensive research into its etiology. Alteration in the production of vascular endothelial growth factor (VEGF), a biomarker of endothelial dysfunction, is associated with pre-eclampsia although conflicting reports have been reported. The aim of the study was to determine and compare maternal serum levels of VEGF among pre-eclamptics, normotensive non pregnant and pregnant women.This was a cross-sectional study involving 100 women with pre-eclampsia, 102 women with normotensive pregnancy and 75 normotensives who were not pregnant. The study was carried out at Korle Bu Teaching Hospital (KBTH) from April to June in 2011. Basic socio-demographic and obstetric data were obtained by means of structured questionnaire. Following venesection, about 5mls of blood was sampled from the participants for the various tests. Enzyme Linked Immunosorbent Assay was used to determine the maternal serum levels of free VEGF. Data analysis was performed using SPSS version 20.ResultsSignificant reduction in median serum levels of free VEGF was seen in both, normal pregnant [84.06 pg/ml (IQR: 78.90–99.67)] and pre-eclamptic women [4.71 pg/ml, (IQR: 3.41–7.93)] compared to the non-pregnant (395.85 pg/ml, IQR 234.93–625) with p < 0.001; the reduction was far greater in the pre-eclamptic group compared to that of normotensive pregnant group (p < 0.001). Early-onset pre-eclampsia had significantly more severe reduction in free VEGF levels (3.89, IQR: 2.60–5.67 pg/ml) compared to that of late onset PE (5.23, IQR: 3.78–16.97 pg/ml) with p<0.001 indicating a severer endothelial damage in former.ConclusionsEndothelial dysfunction contributes significantly to the pathogenesis of pre-eclampsia as demonstrated by profound decrease in maternal serum VEGF levels in PE compared to normotensive pregnancy and non-pregnancy state. The pathophysiology of early-onset pre-eclampsia may be partly explained by marked reduction in free serum VEGF levels with resultant severe endothelial dysfunction.

Highlights

  • Pre-eclampsia (PE) remains a disease of theories despite extensive research into its etiology

  • This study aimed at determining whether or not endothelial dysfunction has a significant contribution in the pathogenesis of preeclampsia by comparing maternal serum levels of free vascular endothelial growth factor (VEGF) in normotensive non-pregnant, normotensive pregnant and pre-eclamptic women

  • This study has demonstrated a significant reduction in maternal serum free VEGF levels in both normotensive pregnancy and pre-eclampsia compared to the normotensive non-pregnant state

Read more

Summary

Introduction

Pre-eclampsia (PE) remains a disease of theories despite extensive research into its etiology. The aim of the study was to determine and compare maternal serum levels of VEGF among pre-eclamptics, normotensive non pregnant and pregnant women. Pre-eclampsia (PE) is a multi-system pregnancy specific disorder, characterized by new onset of hypertension and proteinuria developing after the gestational age of 20 weeks [1,2,3]. It remains a major cause of both maternal and perinatal mortality and morbidity [1,2,3,4]. Adequate knowledge about the pathophysiologic role of VEGF in pre-eclampsia is vital in devising appropriate screening tests to facilitate early detection and treatment of the disease

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call